# Compugen (CGEN.US)

Canonical: https://gigainvestors.com/s/CGEN

Analysis as of: 2026-10-16T07:27:23.254Z. Financial observations: FY1999–FY2026.

Listing currency: USD. Reporting currency: USD.

## Verdict

Not a wonderful business

Quality tests for Buy: not passed (profit record: fail; earnings resilience is evidence only). Published buy qualification: no.

Share price: $2.08 per share; close as of 2026-10-15.

## Checklist

### understandable: fail

- 3 revenue declines in the last 10 years (informational)

- more than 2 net loss years

- negative average operating margin

- operating margin variation exceeds 0.35

- Financial history: 10 years

- Years with declining revenue: 3

- Years with a net loss: 8

- Operating margin variation: 1.48×

Chart: Operating margin; fiscal year observations.

- FY2018: -1.30×

- FY2020: -15.75×

- FY2021: -5.85×

- FY2022: -4.72×

- FY2023: -0.39×

- FY2024: -0.53×

- FY2025: 0.43×

- LTM to Jun 2026: 0.41×

### moat: fail

- Years with nonpositive invested capital use equity plus debt and leases; positive earnings with no positive capital are shown above 100%.

- ROIC median below threshold

- ROIC worst years below threshold (more than 1 bad year allowed)

- ROIC, median of available years: -40.3%

- ROIC, second-lowest year: -99.8%

- Years with nonpositive capital: 8

- Capital spending / revenue: 2.9%

- ROIC including acquisitions, ten-year median: -867.6%

Chart: ROIC excluding acquisitions; fiscal year observations.

- FY2016: -1292.2%

- FY2017: -99.8%

- FY2018: -45.6%

- FY2019: -54.5%

- FY2020: -20.2%

- FY2021: -25.3%

- FY2022: -35.1%

- FY2023: -63.3%

- FY2024: -20.3%

- FY2025: 29.6%

### economics: fail

- owner earnings cash conversion below threshold

- Cash conversion uses consolidated totals: No

- Owner earnings, five-year total: -$63M

- Net income, five-year total: -$64M

- Return on incremental invested capital: >100%

- Working capital / revenue, annual change: 131.7 pp

- Working capital / revenue, final three-year average: 54.8%

Chart: Owner earnings · five years; fiscal year observations.

- FY2021: -$33M

- FY2022: -$34M

- FY2023: -$18M

- FY2024: -$14M

- FY2025: $36M

### management: fail

- Historical market-dollar context (not the management verdict): 2016 to 2025 (9 years)

- buybacks unrelated to price (informational)

- ROIC first 3 years vs last 3 years: -99.8% vs -20.3%

- Per-share earnings: -0.62 to -0.16 (three-year endpoint medians)

- per-share value declined or ends nonpositive

- five-year and ten-year diluted share growth both above threshold

- Management verdict uses per-share economic progress: Yes

- Ordinary dilution, 10-year annual growth: 6.4%

- Ordinary dilution, 5-year annual growth: 3.3%

- Market cap gain: -$116M

- Cumulative retained earnings: -$182M

- Diluted shares, 10-year annual growth: 6.4%

- Diluted shares, 5-year annual growth: 3.3%

- $1 test, starting fiscal year: FY2016

- $1 test, ending fiscal year: FY2025

- Per-share value change: $0.46

- Per-share value, starting three-year median: -$0.62

- Per-share value, ending three-year median: -$0.16

- Buyback history: 0 years

- Debt-funded buybacks: No

- Acquisition spending: $0

- Cumulative net income, 10 years: -$210M

- ROIC, first three-year median: -99.8%

- ROIC, last three-year median: -20.3%

Chart: Earnings per share; fiscal year observations.

- FY2016: -$0.62

- FY2017: -$0.72

- FY2018: -$0.41

- FY2019: -$0.43

- FY2020: -$0.34

- FY2021: -$0.39

- FY2022: -$0.39

- FY2023: -$0.21

- FY2024: -$0.16

- FY2025: $0.38

### accounting: pass

- Sloan accruals: 2.4%

- Receivables to sales index (DSRI): 0.42×

- Restructuring years, last five: 0

- Stock compensation / operating cash flow: 5.9%

- Earnings backed by cash: Yes

- Operating cash / earnings: 0.90×

- Accounting red flags: 0

- Goodwill and intangibles / equity: 0.00×

Chart: Sloan accruals; fiscal year observations.

- FY2016: -16.4%

- FY2017: -16.5%

- FY2018: -17.5%

- FY2019: 1.0%

- FY2020: 0.8%

- FY2021: -7.7%

- FY2022: 0.4%

- FY2023: 14.1%

- FY2024: -55.5%

- FY2025: 2.4%

## Holders

- [David Katz](https://gigainvestors.com/MAVFX): tracked 13F investor; follow the investor page for holding quarter and amounts.

## Price story

Down 68% since Oct 2021 · "Compugen Ltd (NASDAQ:CGEN) Reports Q2 2025 Revenue and EPS Miss, Shares Drop in Premarket" (chartmill.com, Aug 2025) · sales +1.7%

Story as of 2026-10-16T09:58:29.783Z; price observation 2026-10-15.

- 2025-08-06: Compugen Ltd (NASDAQ:CGEN) Reports Q2 2025 Revenue and EPS Miss, Shares Drop in Premarket ([chartmill.com](https://www.chartmill.com/news/CGEN/Chartmill-32470-Compugen-Ltd-NASDAQCGEN-Reports-Q2-2025-Revenue-and-EPS-Miss-Shares-Drop-in-Premarket))

### Sales · FY2025–2026

sales +1.7%; source https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/zk2634416.htm; observed 2026-03-02.

- FY2017: $0 

- FY2018: $18M 

- FY2019: $0 

- FY2020: $2.0M 

- FY2021: $6.0M 

- FY2022: $7.5M 

- FY2023: $33M 

- FY2024: $28M 

- FY2025: $73M 

- FY2026: $74M 

### Gross margin · FY2025

gross margin 87.3%; source https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/zk2634416.htm; observed 2026-03-02.

- FY2016: 68.7% 

- FY2018: 94.2% 

- FY2020: 97.0% 

- FY2021: 88.7% 

- FY2022: 87.0% 

- FY2023: 94.0% 

- FY2024: 71.5% 

- FY2025: 87.3% 

## Owner memo

Memo as of 2026-10-16T08:06:05.509Z.

### How it makes money

Operates in biotechnology; annual sales are USD 72.8 million.

- Source: https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/zk2634416.htm (filed 2026-03-02); FY2025: revenue 72764000; grossProfit 63513000; margin = grossProfit / revenue.

### Why customers stay

Margins ranged from 71.5% to 94% during 2023–25; it lost 40.3% on its capital.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-02); FY2023: grossProfit / revenue = 94%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-02); FY2024: grossProfit / revenue = 71.5%.

- Source: https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/zk2634416.htm (filed 2026-03-02); FY2025: grossProfit / revenue = 87.3%.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-02); 10-year return on capital observations [[2016,-12.921972891566265],[2017,-0.998005673950488],[2018,-0.45592928489787804],[2019,-0.5445096541683573],[2020,-0.2023769398444871],[2021,-0.2531770876163848],[2022,-0.35105156711261853],[2023,-0.632584283513097],[2024,-0.20343599764811676],[2025,0.29594015125522316]]; median -0.4034904260052483. ROIC follows the displayed moat series; financial companies use return on tangible equity.

### Where the cash goes

Paid no dividends in 10 years.

- Source: https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/zk2634416.htm (filed 2026-03-02); FY2025: growth capex 0; upkeep 306000; owner earnings 35512000. Growth capex / owner earnings = 0.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-02); Dividend observations: [[2016,0],[2017,0],[2018,0],[2019,0],[2020,0],[2021,0],[2022,0],[2023,0],[2024,0],[2025,0]]. Zero only counted when supported by a complete cash-flow statement.

### Are managers owners

Insiders own 0.2% of the company.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-10-05); CGEN.US SharesStats.PercentInsiders = 0.183 percentage points; cache date 2026-10-05.

### What the price says

The price is 2.7 times annual sales.

- Source: https://eodhd.com/financial-apis/stock-etfs-fundamental-data-feeds/ (filed 2026-03-02); Closing price 2.08 USD; reporting-to-trading FX 1; FY2025 annual sales per share 0.7756108897755812; price multiple 2.681757086471332. FY2025 cash earnings/share 0.3785318827677208. Closing-price date 2026-10-15.

## Monthly share-price history (USD per share)

- 2016-10: $5.75 per share

- 2016-11: $6.05 per share

- 2016-12: $5.10 per share

- 2017-01: $4.75 per share

- 2017-02: $4.25 per share

- 2017-03: $4.30 per share

- 2017-04: $4.05 per share

- 2017-05: $4.80 per share

- 2017-06: $3.80 per share

- 2017-07: $4.05 per share

- 2017-08: $3.05 per share

- 2017-09: $3.80 per share

- 2017-10: $3.00 per share

- 2017-11: $2.45 per share

- 2017-12: $2.50 per share

- 2018-01: $3.00 per share

- 2018-02: $4.00 per share

- 2018-03: $4.45 per share

- 2018-04: $3.50 per share

- 2018-05: $3.75 per share

- 2018-06: $3.30 per share

- 2018-07: $3.15 per share

- 2018-08: $3.90 per share

- 2018-09: $3.85 per share

- 2018-10: $3.08 per share

- 2018-11: $3.46 per share

- 2018-12: $2.17 per share

- 2019-01: $3.45 per share

- 2019-02: $3.44 per share

- 2019-03: $4.14 per share

- 2019-04: $3.50 per share

- 2019-05: $2.80 per share

- 2019-06: $3.84 per share

- 2019-07: $3.24 per share

- 2019-08: $3.85 per share

- 2019-09: $4.23 per share

- 2019-10: $5.13 per share

- 2019-11: $6.09 per share

- 2019-12: $5.96 per share

- 2020-01: $7.20 per share

- 2020-02: $9.07 per share

- 2020-03: $7.26 per share

- 2020-04: $14.49 per share

- 2020-05: $15.39 per share

- 2020-06: $15.02 per share

- 2020-07: $14.41 per share

- 2020-08: $17.29 per share

- 2020-09: $16.25 per share

- 2020-10: $12.89 per share

- 2020-11: $12.84 per share

- 2020-12: $12.11 per share

- 2021-01: $12.16 per share

- 2021-02: $9.33 per share

- 2021-03: $8.59 per share

- 2021-04: $8.63 per share

- 2021-05: $7.68 per share

- 2021-06: $8.28 per share

- 2021-07: $6.79 per share

- 2021-08: $7.02 per share

- 2021-09: $5.97 per share

- 2021-10: $6.49 per share

- 2021-11: $4.42 per share

- 2021-12: $4.30 per share

- 2022-01: $3.55 per share

- 2022-02: $3.09 per share

- 2022-03: $3.22 per share

- 2022-04: $2.38 per share

- 2022-05: $1.85 per share

- 2022-06: $1.85 per share

- 2022-07: $1.61 per share

- 2022-08: $1.17 per share

- 2022-09: $0.66 per share

- 2022-10: $0.95 per share

- 2022-11: $1.20 per share

- 2022-12: $0.72 per share

- 2023-01: $0.87 per share

- 2023-02: $0.79 per share

- 2023-03: $0.70 per share

- 2023-04: $0.59 per share

- 2023-05: $1.02 per share

- 2023-06: $1.14 per share

- 2023-07: $1.16 per share

- 2023-08: $1.14 per share

- 2023-09: $0.93 per share

- 2023-10: $0.76 per share

- 2023-11: $0.66 per share

- 2023-12: $1.98 per share

- 2024-01: $2.41 per share

- 2024-02: $2.58 per share

- 2024-03: $2.58 per share

- 2024-04: $1.93 per share

- 2024-05: $2.17 per share

- 2024-06: $1.68 per share

- 2024-07: $1.77 per share

- 2024-08: $2.10 per share

- 2024-09: $1.81 per share

- 2024-10: $1.60 per share

- 2024-11: $1.59 per share

- 2024-12: $1.53 per share

- 2025-01: $2.33 per share

- 2025-02: $1.92 per share

- 2025-03: $1.46 per share

- 2025-04: $1.60 per share

- 2025-05: $1.47 per share

- 2025-06: $1.78 per share

- 2025-07: $1.45 per share

- 2025-08: $1.41 per share

- 2025-09: $1.47 per share

- 2025-10: $1.77 per share

- 2025-11: $1.56 per share

- 2025-12: $1.53 per share

- 2026-01: $1.84 per share

- 2026-02: $1.81 per share

- 2026-03: $2.13 per share

- 2026-04: $2.66 per share

- 2026-05: $2.63 per share

- 2026-06: $2.14 per share

- 2026-07: $2.35 per share

- 2026-08: $2.56 per share

- 2026-09: $2.38 per share

- 2026-10: $2.08 per share

## Annual estimated value (USD per share)

Historical values use today's bond yield for every fiscal year

Historical values use today's FX rate into trading currency for every fiscal year

Historical values use current restated fundamentals and current commodity classification; they are not point-in-time estimates

## Sources

[Original 20-F filing](https://www.sec.gov/Archives/edgar/data/1119774/000117891326000663/zk2634416.htm); period 2025-12-31, filed 2026-03-02.

Estimates depend on assumptions and are not guarantees or investment advice. Underlying data remains subject to its source licenses; public reading does not grant bulk redistribution rights.

## Reported holder observations

- [David Katz](https://gigainvestors.com/MAVFX): 93,833 CGEN shares; USD 223,000 reported position value; 0.02% of portfolio; hold; quarter 2026 Q3.

# CGEN — Compugen Ltd

Held by 1 investor · USD 223,000 total · 2026 Q3 · reported price USD 2.38 (split-adjusted).
Page: https://gigainvestors.com/s/CGEN

## Holders (2026 Q3)

| Investor | Value | % of their portfolio | This quarter |
|---|---:|---:|---|
| David Katz (https://gigainvestors.com/MAVFX) | USD 223,000 | <0.1% | hold |

## Total held by quarter

- 2020 Q1: USD 694,782 · 1 holder · USD 7.26
- 2020 Q2: USD 1,434,410 · 1 holder · USD 15.02
- 2020 Q3: USD 1,616,875 · 1 holder · USD 16.25
- 2020 Q4: USD 1,277,605 · 1 holder · USD 12.11
- 2021 Q1: USD 919,130 · 1 holder · USD 8.59
- 2021 Q2: USD 871,354 · 1 holder · USD 8.28
- 2021 Q3: USD 628,259 · 1 holder · USD 5.97
- 2021 Q4: USD 422,415 · 1 holder · USD 4.30
- 2022 Q1: USD 316,320 · 1 holder · USD 3.22
- 2022 Q2: USD 177,600 · 1 holder · USD 1.85
- 2022 Q3: USD 75,240 · 1 holder · USD 0.66
- 2022 Q4: USD 78,952 · 1 holder · USD 0.72
- 2023 Q1: USD 76,759 · 1 holder · USD 0.70
- 2023 Q2: USD 125,008 · 1 holder · USD 1.14
- 2023 Q3: USD 101,980 · 1 holder · USD 0.93
- 2023 Q4: USD 217,119 · 1 holder · USD 1.98
- 2024 Q1: USD 234,349 · 1 holder · USD 2.58
- 2024 Q2: USD 152,599 · 1 holder · USD 1.68
- 2024 Q3: USD 169,838 · 1 holder · USD 1.81
- 2024 Q4: USD 143,564 · 1 holder · USD 1.53
- 2025 Q1: USD 136,996 · 1 holder · USD 1.46
- 2025 Q2: USD 167,023 · 1 holder · USD 1.78
- 2025 Q3: USD 137,935 · 1 holder · USD 1.47
- 2025 Q4: USD 143,564 · 1 holder · USD 1.53
- 2026 Q1: USD 199,864 · 1 holder · USD 2.13
- 2026 Q2: USD 201,000 · 1 holder · USD 2.14
- 2026 Q3: USD 223,000 · 1 holder · USD 2.38